Free Trial

Mereo BioPharma Group (MREO) SEC Filings & 10K Form

Mereo BioPharma Group logo
$2.30 +0.17 (+7.98%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.37 +0.07 (+2.83%)
As of 04/17/2025 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mereo BioPharma Group SEC Filings

DateFilerForm TypeView
04/08/2025
5:45 AM
Mereo BioPharma Group (Filer)
Form ARS
04/08/2025
5:41 AM
Mereo BioPharma Group (Filer)
Form DEF 14A
04/04/2025
11:39 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G
03/26/2025
6:44 AM
Mereo BioPharma Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2025
6:38 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:34 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:30 PM
Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Ekblom Anders (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:07 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
5:32 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
10:37 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
11/14/2024
10:44 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G/A
11/12/2024
3:49 PM
Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
09/16/2024
7:46 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:47 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:48 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:50 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:47 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:50 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:57 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:05 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
5:13 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:35 PM
Mereo BioPharma Group (Subject)
PAKIANATHAN DEEPIKA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:19 AM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
7:09 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
10:46 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
06/27/2024
3:15 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Last Time Stocks Looked Like This, They Didn’t Move For 16 Years (Ad)

There is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen yourself with all this recent volatility... The wheels are falling off the United States stock market.

Click here to view my new presentation now.
06/27/2024
3:15 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:13 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:13 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:14 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:21 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:53 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/24/2024
5:58 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144/A
06/24/2024
6:00 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/24/2024
6:04 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144/A
06/24/2024
6:04 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
Form 144/A
06/20/2024
3:27 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:30 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:32 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:34 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:16 PM
Mereo BioPharma Group (Issuer)
Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
8:15 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2024
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
05/23/2024
8:54 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:38 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:16 PM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:49 PM
Mereo BioPharma Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/15/2024
3:19 PM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:36 AM
Mereo BioPharma Group (Filer)
Form ARS
04/24/2024
6:30 AM
Mereo BioPharma Group (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MREO) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners